Get Started

FGEN

FibroGen (FGEN)

FibroGen Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:FGEN

<< Previous 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 Next >>

Date	Time	Source	Headline	Symbol	Company
11/01/2018	1:49PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:FGEN	FibroGen Inc
10/30/2018	8:02AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:FGEN	FibroGen Inc
10/30/2018	4:00AM	GlobeNewswire Inc.	ASN Kidney Week 2018: Data Presented from Two Japanese Phase 3 Studies on Roxadustat in the Treatment of Anemia Associated wi...	NASDAQ:FGEN	FibroGen Inc
10/26/2018	6:02AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:FGEN	FibroGen Inc
10/25/2018	7:49PM	GlobeNewswire Inc.	FibroGen Presents Results from Two Phase 3 Studies of Roxadustat for the Treatment of Anemia Associated with Chronic Kidney D...	NASDAQ:FGEN	FibroGen Inc
10/16/2018	4:27PM	GlobeNewswire Inc.	FibroGen Announces Four Clinical Presentations on Roxadustat at Upcoming American Society of Nephrology Kidney Week 2018 Annu...	NASDAQ:FGEN	FibroGen Inc
10/09/2018	5:10PM	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:FGEN	FibroGen Inc
10/04/2018	6:01PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:FGEN	FibroGen Inc
10/01/2018	8:02AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:FGEN	FibroGen Inc
10/01/2018	8:00AM	GlobeNewswire Inc.	Astellas Submits New Drug Application in Japan of Roxadustat for The Treatment of Anemia Associated with Chronic Kidney Dise...	NASDAQ:FGEN	FibroGen Inc
09/28/2018	7:12PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:FGEN	FibroGen Inc
09/21/2018	6:19PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:FGEN	FibroGen Inc
09/21/2018	6:18PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:FGEN	FibroGen Inc
09/20/2018	8:32AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:FGEN	FibroGen Inc
09/18/2018	6:20PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:FGEN	FibroGen Inc
09/14/2018	5:39PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:FGEN	FibroGen Inc
09/12/2018	4:59PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:FGEN	FibroGen Inc
09/12/2018	4:55PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:FGEN	FibroGen Inc
09/12/2018	9:30AM	GlobeNewswire Inc.	FibroGen Receives Fast Track Designation From the U.S. FDA for Pamrevlumab for the Treatment of Idiopathic Pulmonary Fibrosis...	NASDAQ:FGEN	FibroGen Inc
09/12/2018	9:26AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:FGEN	FibroGen Inc
09/07/2018	6:30PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:FGEN	FibroGen Inc
09/05/2018	6:38PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:FGEN	FibroGen Inc
08/24/2018	7:33PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:FGEN	FibroGen Inc
08/22/2018	7:26PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:FGEN	FibroGen Inc
08/17/2018	5:32PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:FGEN	FibroGen Inc
08/17/2018	5:30PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:FGEN	FibroGen Inc
08/10/2018	4:49PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:FGEN	FibroGen Inc
08/07/2018	4:56PM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:FGEN	FibroGen Inc
08/07/2018	4:54PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:FGEN	FibroGen Inc
08/07/2018	4:02PM	GlobeNewswire Inc.	FibroGen Reports Second Quarter 2018 Financial Results	NASDAQ:FGEN	FibroGen Inc